brianajackson /
9 June 2017Americas

PTAB awards victory to Bass in Diprivan IPR

The Patent Trial and Appeal Board (PTAB) has handed victory to hedge fund manager Kyle Bass in an inter partes review (IPR) against a European healthcare company Fresenius Kabi-owned patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at